Published in
BioMed Central, BMC Infectious Diseases, 1(17), 2017
DOI: 10.1186/s12879-017-2665-5
Links
Tools
The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases
Journal article published in 2017 by
Kazuma Yagi,
Makoto Ishii 
,
Ho Namkoong,
Takahiro Asami,
Osamu Iketani,
Takanori Asakura,
Shoji Suzuki,
Hiroaki Sugiura,
Yoshitake Yamada ,
Tomoyasu Nishimura,
Hiroshi Fujiwara,
Yohei Funatsu,
Yoshifumi Uwamino,
Tetsuro Kamo,
Sadatomo Tasaka
and other authors.
,
Ho Namkoong,
Takahiro Asami,
Osamu Iketani,
Takanori Asakura,
Shoji Suzuki,
Hiroaki Sugiura,
Yoshitake Yamada ,
Tomoyasu Nishimura,
Hiroshi Fujiwara,
Yohei Funatsu,
Yoshifumi Uwamino,
Tetsuro Kamo,
Sadatomo Tasaka
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 